The present invention relates to the new use and target of a compound of formula I such as terazosin. In particular, the present invention relates to the use of the compound of formula I in the preparation of drugs used as an apoptosis inhibitor or drugs for treating and/or preventing sepsis and the complications thereof. The present invention provides a new method and direction for inhibiting apoptosis and treating and/or preventing sepsis and the complications thereof.

The invention relates to a pharmaceutical composition for treating dependency in human beings, including the following two active principles: cyproheptadine, which is selected to be a compound having an antagonistic activity against the 5-HT2 serotonin receptors

Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine